Cargando…

Re: Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients

Detalles Bibliográficos
Autores principales:	Raynaud, Jean-Sébastien, Darmon-Kern, Elisabeth, Lancelot, Eric, Laurent, Anne-Coline, Desché, Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2018
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951871/ https://www.ncbi.nlm.nih.gov/pubmed/29476438 http://dx.doi.org/10.1007/s11547-018-0864-9

Ejemplares similares

Lack of evidence of a relationship between magnetic resonance signal intensity changes in the globus pallidus and dentate nucleus, and repeated administrations of gadoterate meglumine in children
por: Lancelot, Eric, et al.
Publicado: (2017)

Anaphylaxis to gadobutrol and gadoterate meglumine in a patient with low grade astrocytoma
por: Montalvo, Juan Manuel Escobar, et al.
Publicado: (2014)

Gadolinium Clearance in the First 5 Weeks After Repeated Intravenous Administration of Gadoteridol, Gadoterate Meglumine, and Gadobutrol to rats
por: Bussi, Simona, et al.
Publicado: (2021)

Comprehensive Speciation Analysis of Residual Gadolinium in Deep Cerebellar Nuclei in Rats Repeatedly Administered With Gadoterate Meglumine or Gadodiamide
por: Strzeminska, Izabela, et al.
Publicado: (2022)

Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study)
por: Deray, Gilbert, et al.
Publicado: (2012)

Gadolinium Retention and Clearance in the Diabetic Brain after Administrations of Gadodiamide, Gadopentetate Dimeglumine, and Gadoterate Meglumine in a Rat Model
por: Wang, Shu-ting, et al.
Publicado: (2019)

Gadolinium Retention as a Safety Signal: Experience of a Manufacturer
por: Lancelot, Eric, et al.
Publicado: (2020)

Longitudinal Assessment of Dentate Nuclei Relaxometry during Massive Gadobutrol Exposure
por: Tedeschi, Enrico, et al.
Publicado: (2017)

Gadoterate meglumine decreases ADC values of breast lesions depending on the b value combination
por: Arponen, Otso, et al.
Publicado: (2018)

Observational study on the safety profile of gadoterate meglumine in 35,499 patients: The SECURE study
por: Soyer, Philippe, et al.
Publicado: (2016)

Safety of gadoterate meglumine in over 1600 children included in the prospective observational SECURE study
por: Chang, De-Hua, et al.
Publicado: (2019)

What Evidence Is There That Gadobutrol Causes Increasing Signal Intensity within the Dentate Nucleus and Globus Pallidus on Unenhanced T1W MRI in Patients with RRMS?
por: Agris, Jacob, et al.
Publicado: (2015)

Single-Dose Gadoterate Meglumine for 3T Late Gadolinium Enhancement MRI for the Assessment of Chronic Myocardial Infarction: Intra-Individual Comparison with Conventional Double-Dose 1.5T MRI
por: Lim, Jiyeon, et al.
Publicado: (2018)

A Pharmacokinetics, Efficacy, and Safety Study of Gadoterate Meglumine in Pediatric Subjects Aged Younger Than 2 Years
por: Scala, Mario, et al.
Publicado: (2018)

Influence of aging and gadolinium exposure on T1, T2, and T2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-T brain MR imaging
por: Krug, Kathrin Barbara, et al.
Publicado: (2021)

Two cases of nephrogenic systemic fibrosis after exposure to the macrocyclic compound gadobutrol
por: Elmholdt, Tina Rask, et al.
Publicado: (2010)

Respiratory anomalies associated with gadoxetate disodium and gadoterate meglumine: compressed sensing MRI revealing physiologic phenomena during the entire injection cycle
por: Glessgen, Carl Guillaume, et al.
Publicado: (2021)

Prospective T1 mapping to assess gadolinium retention in brain after intrathecal gadobutrol
por: Ringstad, Geir, et al.
Publicado: (2023)

Safety of Gadoterate Meglumine (Gd-DOTA) as a Contrast Agent for Magnetic Resonance Imaging: Results of a Post-Marketing Surveillance Study in Japan
por: Ishiguchi, Tsuneo, et al.
Publicado: (2012)

Fatal anaphylactic reaction to intravenous gadobutrol, a gadolinium-based MRI contrast agent
por: Franckenberg, Sabine, et al.
Publicado: (2017)

Gadolinium Accumulation and Toxicity on In Vitro Grown Stevia rebaudiana: A Case-Study on Gadobutrol
por: Scurtu, Violeta Florina, et al.
Publicado: (2022)

Visible T1-hyperintensity of the dentate nucleus after multiple administrations of macrocyclic gadolinium-based contrast agents: yes or no?
por: Splendiani, Alessandra, et al.
Publicado: (2019)

Different Impact of Gadopentetate and Gadobutrol on Inflammation-Promoted Retention and Toxicity of Gadolinium Within the Mouse Brain
por: Anderhalten, Lina, et al.
Publicado: (2022)

Signal Increase on Unenhanced T1-Weighted Images in the Rat Brain After Repeated, Extended Doses of Gadolinium-Based Contrast Agents: Comparison of Linear and Macrocyclic Agents
por: Jost, Gregor, et al.
Publicado: (2016)

Does Age Interfere With Gadolinium Toxicity and Presence in Brain and Bone Tissues?: A Comparative Gadoterate Versus Gadodiamide Study in Juvenile and Adult Rats
por: Fretellier, Nathalie, et al.
Publicado: (2019)

Absence of potential gadolinium toxicity symptoms following 22,897 gadoteric acid (Dotarem®) examinations, including 3,209 performed on renally insufficient individuals
por: Young, Laura K., et al.
Publicado: (2018)

Gadobutrol: Fatal anaphylaxis: case report
Publicado: (2021)

Breast lesion detection and characterization with contrast‐enhanced magnetic resonance imaging: Prospective randomized intraindividual comparison of gadoterate meglumine (0.15 mmol/kg) and gadobenate dimeglumine (0.075 mmol/kg) at 3T
por: Clauser, Paola, et al.
Publicado: (2018)

Comparison of linear versus macrocyclic gadolinium chelates in rat skeletal muscle
por: Balik, Mehmet Sabri, et al.
Publicado: (2022)

Gadobutrol in Renally Impaired Patients: Results of the GRIP Study
por: Michaely, Henrik J., et al.
Publicado: (2017)

Gadobutrol in India—A Comprehensive Review of Safety and Efficacy
por: Endrikat, Jan, et al.
Publicado: (2017)

Gadobutrol: A Review in Contrast-Enhanced MRI and MRA
por: Scott, Lesley J.
Publicado: (2018)

Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents
por: Lohrke, Jessica, et al.
Publicado: (2017)

Gadolinium Accumulation in the Deep Cerebellar Nuclei and Globus Pallidus After Exposure to Linear but Not Macrocyclic Gadolinium-Based Contrast Agents in a Retrospective Pig Study With High Similarity to Clinical Conditions
por: Boyken, Janina, et al.
Publicado: (2018)

A clinical combined gadobutrol bolus and slow infusion protocol enabling angiography, inversion recovery whole heart, and late gadolinium enhancement imaging in a single study
por: Tandon, Animesh, et al.
Publicado: (2016)

Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats
por: Bussi, Simona, et al.
Publicado: (2017)

Synthesis of a gadolinium based-macrocyclic MRI contrast agent for effective cancer diagnosis
por: Jeong, Yohan, et al.
Publicado: (2018)

Gadolinium retention and clearance after administration of macrocyclic magnetic resonance contrast agents to rats
por: Bussi, Simona, et al.
Publicado: (2019)

Macrocyclic MR contrast agents: evaluation of multiple-organ gadolinium retention in healthy rats
por: Bussi, Simona, et al.
Publicado: (2020)

Gadobutrol versus gadofosveset-trisodium in MR venography of the lower extremities
por: Arnoldussen, Carsten W. K. P., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vhqldachd6m6a6k92i152daf88